Pdp (68071 2883 1)
Gabapentin
Product Images NDC 68071-2883
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-2883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)
Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)
This appears to be a clinical study related to pain management using a drug called Gabapentin. The study includes a period of dose titration followed by a fixed dose period. It also references a pain score measurement called the "Moan Pain Score," with a value of 10 provided. However, without additional context, it is difficult to provide more information about the study's methodology or results.*
Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This appears to be a chart or table with information related to a pain study involving a fixed dose period of four weeks. The study includes a placebo group and two groups taking different doses of Gabapentin. The chart tracks the mean pain score over time, with measurements taken at baseline and during weeks 1 through 7.*
Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
